App-safe HK / Shenzhen ops
All targets
Must contactBiomanufacturing88

National Biomanufacturing Industry Innovation Center (+ Xinmei / Yinxing Synthetic Biology Industrial Park)

国家生物制造产业创新中心(及新湖/银星合成生物产业园)

China's first national-level biomanufacturing innovation platform, purpose-built to close the '1→10' lab-to-pilot scale-up gap — the single best ecosystem gateway to actual pilot-fermentation capacity and tenant companies in Guangming.

Location
Guangming Science City, Yinxing Synthetic Biology Industrial Park · Shenzhen
Visit window
From the Nanshan base · Jul 13–31
Source status
high confidenceprofiled

Next action

Prepare the private outreach route and meeting ask; keep contact details out of the app.

Why now: Visit window · From the Nanshan base · Jul 13–31

What they do

NDRC-approved (Jul 2023), built from Jul 2024, and in trial operation from Dec 2025 in Guangming Science City. Led by SIAT/CAS and operated by Shenzhen Biomanufacturing Industry Innovation Center Co. (reg. capital ~RMB 700M; among 34 co-builders: SDIC, China Merchants, Shum Yip, Bloomage, Guangxin, Huaheng, Leo-King). It runs six platforms — automated biomanufacturing, cross-scale validation, high-throughput process development, pilot scale-up and GMP, large-scale carrier prep and QC, and bio-information computing — across green/low-carbon, bio-agriculture and health.

The associated Yinxing/Xinmei park hosts biomaterials, biological-food, bioreagent and cosmetics tenants for proof-of-concept to pilot-scale work.

Why it matters

Bullseye for the pilot-fermentation priority and strong on AI-in-biotech (automation plus bio-information computing). Bio-agriculture is one of three official fields, aligning directly with Pure Advance's AI-accelerated microbial biocontrols.

As a government/CAS-backed national platform it is a gateway rather than a single vendor: one introduction can route Pure Advance to shared pilot/GMP infrastructure (the '1→10' scale-up gap biocontrols must clear) plus relevant tenant companies in one Guangming visit. The same capacity could also serve a biologically produced Coolvex ingredient.

The #1 thing to clarify is whether and how a foreign non-resident startup can access the platform.

Visit objective & route

Secure an official access briefing on whether/how a foreign non-resident startup can run pilot-fermentation and GMP batches, and get introductions to 2-3 agri-microbial or industrial-fermentation resident tenants; treat as the Guangming ecosystem gateway.

Approach route

Route via InnoX / program organisers and/or the SIAT-iSynBio international-cooperation office for an official cluster briefing; do not cold-approach.

Talking points

  • Is the pilot scale-up & GMP platform operational now (Jul 2026), and what fermentation volumes/modes does the pilot (中试) line cover?
  • Can a foreign, non-resident startup run a pilot batch — fee-for-service, co-development, or resident-only — and at what cost and lead-time?
  • Do you support live-microbial biopesticide/biocontrol scale-up (not just enzymes), and what is the biosafety ceiling for foreign-origin strains?
  • Can you introduce us to resident agri-microbial tenants (e.g. 中农秸美) and to Synceres next door?
  • Bring: a Pure Advance one-pager (AI-accelerated microbial biocontrols), a pilot-fermentation needs summary (strains, volumes, downstream), and an NDA template.

Open questions

  • Whether overseas startups can access shared pilot-fermentation infrastructure, and on what terms (fee / partnership / introduction-only) — currently unpublished.
  • Which platforms are operational versus still commissioning by Jul 2026 (trial operation began Dec 2025).
  • Which resident tenants run microbial/agri-bio fermentation (lead) and, secondarily, topical/cosmetic biomaterials.
  • The correct route/contact for a foreign-founder cluster visit in July 2026 (likely InnoX).

Risks & unknowns

  • Trial-operation, not fully live, in mid-2026 — the pilot/GMP platforms are still commissioning.
  • Access terms for a foreign non-resident startup are unpublished; the resident-enterprise model (first cohort already signed) may favour tenants or partner-routed projects.
  • Appointment/introduction-only — route via InnoX or SIAT/iSynBio, do not cold-approach.
  • Guangming is roughly 35-50 km / 60-80 min from the Nanshan base; plan a dedicated Guangming day combined with iSynBio and Synceres.

Private-pack boundary

Contact details, exact address, and appointment logistics are kept in your private pack — verify privately before outreach. This dossier holds public, app-safe intelligence only.